Belluscura (FRA:9VQ) EBIT per Share : €-0.07 (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura EBIT per Share?

Belluscura's EBIT per Share for the six months ended in Jun. 2023 was €-0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.07.

During the past 3 years, the average EBIT per Share Growth Rate was -101.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Belluscura's EBIT per Share or its related term are showing as below:

FRA:9VQ' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -101 Med: -81.15 Max: -61.3
Current: -101

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Belluscura was -61.30% per year. The lowest was -101.00% per year. And the median was -81.15% per year.

FRA:9VQ's 3-Year EBIT Growth Rate is ranked worse than
98.21% of 727 companies
in the Medical Devices & Instruments industry
Industry Median: 5.9 vs FRA:9VQ: -101.00

Belluscura's EBIT for the six months ended in Jun. 2023 was €-5.72 Mil.

Belluscura EBIT per Share Historical Data

The historical data trend for Belluscura's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura EBIT per Share Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

-0.01

-0.04

-0.06

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EBIT per Share	Get a 7-Day Free Trial				-0.03	-0.02	-0.03	-0.03	-0.04

Belluscura EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Belluscura's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.674	/	131.797
=	-0.06

Belluscura's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

	EBIT per Share		(Q: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5.716	/	136.358
=	-0.04

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.07

Belluscura (FRA:9VQ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Belluscura EBIT per Share Related Terms

Thank you for viewing the detailed overview of Belluscura's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines